156 related articles for article (PubMed ID: 22527819)
1. Molecular epidemiology of Pseudomonas aeruginosa in cystic fibrosis patients from Southeast Austria.
Masoud-Landgraf L; Badura A; Eber E; Feierl G; Posch J; Zarfel G; Zach M; Marth E
Wien Klin Wochenschr; 2012 Apr; 124(7-8):262-5. PubMed ID: 22527819
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
[TBL] [Abstract][Full Text] [Related]
3. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
Vosahlikova S; Drevinek P; Cinek O; Pohunek P; Maixnerova M; Urbaskova P; van den Reijden TJ; Dijkshoorn L; Nemec A
Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.
Silbert S; Barth AL; Sader HS
J Clin Microbiol; 2001 Nov; 39(11):3976-81. PubMed ID: 11682517
[TBL] [Abstract][Full Text] [Related]
5. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
[TBL] [Abstract][Full Text] [Related]
6. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.
Speert DP; Campbell ME; Henry DA; Milner R; Taha F; Gravelle A; Davidson AG; Wong LT; Mahenthiralingam E
Am J Respir Crit Care Med; 2002 Oct; 166(7):988-93. PubMed ID: 12359659
[TBL] [Abstract][Full Text] [Related]
9. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
10. Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.
Kuti JL; Pettit RS; Neu N; Cies JJ; Lapin C; Muhlebach MS; Novak KJ; Nguyen ST; Saiman L; Nicolau DP
Diagn Microbiol Infect Dis; 2015 Sep; 83(1):53-5. PubMed ID: 26003469
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Balke B; Hoy L; Weissbrodt H; Häussler S
Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):765-71. PubMed ID: 15605183
[TBL] [Abstract][Full Text] [Related]
13. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
Nazik H; Ongen B; Erturan Z; Salcioğlu M
Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
[TBL] [Abstract][Full Text] [Related]
14. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM
Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against clinical isolates of meropenem-non-susceptible Pseudomonas aeruginosa: A two-centre study.
Mirza HC; Hortaç E; Koçak AA; Demirkaya MH; Yayla B; Güçlü AÜ; Başustaoğlu A
J Glob Antimicrob Resist; 2020 Mar; 20():334-338. PubMed ID: 31568882
[TBL] [Abstract][Full Text] [Related]
16. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
[TBL] [Abstract][Full Text] [Related]
19. Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
Ernst RK; Moskowitz SM; Emerson JC; Kraig GM; Adams KN; Harvey MD; Ramsey B; Speert DP; Burns JL; Miller SI
J Infect Dis; 2007 Oct; 196(7):1088-92. PubMed ID: 17763333
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population.
Middleton MA; Layeghifard M; Klingel M; Stanojevic S; Yau YCW; Zlosnik JEA; Coriati A; Ratjen FA; Tullis ED; Stephenson A; Wilcox P; Freitag A; Chilvers M; McKinney M; Lavoie A; Wang PW; Guttman DS; Waters VJ
Ann Am Thorac Soc; 2018 Jul; 15(7):827-836. PubMed ID: 29911888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
